Navigation Links
Patients and Physicians Express Desire to Switch to Transdermal Drug Delivery, Finds Frost & Sullivan
Date:7/11/2013

colitisRectal drug delivery

Crohn's diseasePsoriasisRheumatoid arthritisFor more information on this research, please email Britni Myers, Corporate Communications, at britni.myers@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

The route of administration and drug delivery technology has a huge bearing on the adoption of, and compliance with, new as well as existing drugs. Among the surveyed physicians, only a quarter were considered early adopters of new drug delivery forms. Accordingly, manufacturers must listen to actual selection criteria and level of satisfaction data collected from end-users to find commercial success among medical practitioners.

"All things considered, physicians usually lean toward the treatment they feel will be most acceptable to their patients in order to ensure good compliance," said Frost & Sullivan Vice President of Global Research Monali Patel Shastry.

These indicators are highly relevant in the current market scenario, wherein medication adherence is a growing concern, with momentous medical and economic consequences.

"When selecting the optimal drug delivery method, reimbursement incentives for improving adherence and impact on formulary decisions are proven to be important factors," noted Frost & Sullivan Life Sciences Senior Industry Analyst Deborah Toscano. "Drug development pipelines are full of innovative drugs and biologics, and differentiation is increasingly important in this crowded market to gain and maintain market share."

It is important to note the drivers of satisfaction and selection are not always the same across diseases and methods. For example, the several novel oral therapies for multiple sclerosis recently introd
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Senior Home Care Expands In-Home Telemonitoring to Serve Patients in The Villages, Fla. Area
2. Respiratory Motion, Inc. Reports Important New Data On The ExSpiron Respiratory Monitor, The First Monitor To Provide Continuous Minute Ventilation Data In Non-Ventilated Patients
3. TREATMENT OF PRIMARY LIVER CANCER: SARAH STUDY NOW AVAILABLE FOR ALL ELIGIBLE PATIENTS THROUGHOUT FRANCE
4. Shaw Regional Cancer Center Chooses RAD Technologys Temporary Radiotherapy Vault System To Provide Continuous Care To Patients During New Linear Accelerator Installation
5. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions in Triglycerides and APOC-III in Patients with High Triglycerides and Type 2 Diabetes
6. Ibrutinib Monotherapy Clinical Trial Data in Patients with Waldenstroms Macroglobulinemia Presented at the International Conference on Malignant Lymphoma in Lugano, Switzerland
7. New Risk Assessment Tool to Predict Stroke in Patients with Atrial Fibrillation
8. Surveyed U.S. and European Neurologists Identify Better Seizure-Free Efficacy as One of the Greatest Unmet Needs in Treating Partial-Onset Seizures in Refractory Epilepsy Patients
9. Traitement du cancer primaire du foie : létude SARAH désormais accessible aux patients concernés sur lensemble du territoire français
10. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
11. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... SAN DIEGO , July 29, 2014 Pfenex ... its previously announced initial public offering of 8,333,333 shares of ... $6.00 per share. All of the common stock was offered ... 30-day option to purchase up to 1,250,000 additional shares of ... of common stock are traded on the NYSE MKT under ...
(Date:7/29/2014)... 2014 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today reported net income for the quarter ... diluted share, and non-GAAP net income of $94.0 million, or ... a year earlier was $93.3 million, or $0.81 per diluted ... per diluted share.  Net sales for the ...
(Date:7/29/2014)... ALBANY, New York , July 29, 2014 /PRNewswire/ ... published by Transparency Market Research "Surgical Navigation Systems Market ... Systems) - Global Industry Analysis, Size, Share, Growth, Trends ... systems market was valued at USD 218.5 million in ... of 4.5% from 2014 to 2020, to reach an ...
Breaking Medicine Technology:Pfenex Announces Closing of Initial Public Offering 2Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4
... Pa., April 14 Consumers who,purchased raw milk ... after March 18 should discard it immediately due ... Dennis Wolff,said today., Raw milk is milk ... selling raw milk must be permitted and have ...
... cisplatin observed in ovarian carcinoma xenografts, DUBLIN, ... ), a pharmaceutical company dedicated to the discovery, ... and,hematological malignancies, today announced as part of a ... that S-110, its DNA,methyltransferase inhibitor, improves in vivo ...
Cached Medicine Technology:SuperGen's DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine 2SuperGen's DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine 3
(Date:7/30/2014)... 30, 2014 The San Diego personal injury ... are announcing that they are now offering free case reviews ... asbestos exposure. , “Symptoms of asbestos exposure can take ... toxin 30 plus years ago may just now be suffering ... Law Office of Melinda J. Helbock A.P.C. “We want people ...
(Date:7/30/2014)... Connecticut (PRWEB) July 30, 2014 Pain ... new magnetic sports bracelet for pain relief and improved ... strength carbonized titanium embedded in a silicone core that ... also has Germanium and is embedded with scalar energy ... bracelet. , “Pain Free Living has 12 years experience ...
(Date:7/30/2014)... Nuanced Media, a specialist in web design and digital ... Web Design Trends of 2014. The web design trends ... and the medical web design industry throughout the year. , ... grows. Therefore it is important for existing practices and new ... New trends are defined by advances in the medical industry ...
(Date:7/29/2014)... Cucamonga, CA (PRWEB) July 29, 2014 Paul ... Ways to Make More Money in 30 Days” E-book. The ... anyone can use to make extra cash. Examples include downloading ... utilizing unique free websites that help people monetize the assets ... and even unused items they can find in their garage. ...
(Date:7/29/2014)... 30, 2014 Saint Luke’s Medical ... awarded the Patient-Centered Medical Home 2011 Level 3 ... for Quality Assurance. Only one out of four ... Level 2, or Level 3 recognition. , Patients ... Medical Home report faster access to their doctors, ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Offers Case Evaluations for Possible Asbestos Claims 2Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Nuanced Media Releases "Medical Web Design Trends of 2014" Article 2Health News:Create Indestructible Wealth Launches Innovative E-Book: “Realistic Ways to Make More Money in 30 Days” 2Health News:Saint Luke’s Medical Group Awarded Patient-Centered Medical Home 2011 Level 3 Recognition 2
... Cause of Death in Long-Term Survivors of Hereditary Retinoblastoma ... increased risk of death due to a second cancer, ... a very rare cancer of the eye that affects ... of retinoblastoma are at risk of subsequent malignancies but ...
... Hear Public Comments on Comparative Effectiveness Research ... 7 The Federal Coordinating Council for ... listening session on April 14, 2009, in ... comment regarding comparative effectiveness research and the ...
... to worse outcomes , , TUESDAY, April 7 (HealthDay News) ... more likely to die or need a second heart ... according to the results of a U.S. study. , ... who received their first heart transplant at Children,s Hospital ...
... but activity is safe and should be urged, expert says, ... of moderate exercise will not harm people with heart failure ... has found. , That admittedly tepid conclusion comes from a ... at 82 centers in the United States, Canada and France. ...
... Mayo Clinic researchers have discovered the mechanisms behind two ... that may ultimately allow investigators to benchmark progression of ... findings appear in the current online issue of ... by Edward Leof, Ph.D. , Mayo Clinic biochemist, ...
... of Global Breast Cancer Movement Continues Unprecedented Investment ... Committed to caring for those coping with ... of the disease, Susan G. Komen for the ... announced $60 million in research grants to U.S. ...
Cached Medicine News:Health News:Also in the April 7 JNCI 2Health News:Also in the April 7 JNCI 3Health News:Also in the April 7 JNCI 4Health News:Federal Coordinating Council on Comparative Effectiveness Research to Hold Public Listening Session in Washington, DC 2Health News:Heart Transplant Failures More Likely in Poor, Minority Kids 2Health News:Exercise Might Benefit Some With Heart Failure 2Health News:Exercise Might Benefit Some With Heart Failure 3Health News:Mayo researchers discover mechanism of cell type-specific signaling in tumor development 2Health News:Susan G. Komen For The Cure(R) to Invest $60 Million in Research to Accelerate Breast Cancer Cures, Eliminate Disparities, Improve Diagnoses 2Health News:Susan G. Komen For The Cure(R) to Invest $60 Million in Research to Accelerate Breast Cancer Cures, Eliminate Disparities, Improve Diagnoses 3Health News:Susan G. Komen For The Cure(R) to Invest $60 Million in Research to Accelerate Breast Cancer Cures, Eliminate Disparities, Improve Diagnoses 4Health News:Susan G. Komen For The Cure(R) to Invest $60 Million in Research to Accelerate Breast Cancer Cures, Eliminate Disparities, Improve Diagnoses 5
... continuous low-flow nebulizer performance. Patented auxiliary ... allows for optimal medication and Heliox ... OMNI~NEB takes on severe asthma, COPD ... critical care situations. Configure with a ...
... metered dose inhalers., ,ACE ensures prompt, ... canisters. Its versatile design allows it to ... conjunction with an endotracheal airway or resuscitation ... may also be used in conjunction with ...
... Mouthpiece 7FT O 2 Tubing Tee Adapter ... are designed to provide maximum aerosol quality and ... fast treatment time. Each of these high-efficiency nebulizers ... vent seal adapter for use with your ventilator ...
Nebulizer Custom Kit...
Medicine Products: